Through an innovative partnership between EmblemHealth and Dr. Dean Ornish, a preeminent physician and researcher, EmblemHealth launched a first-of-its-kind program for patients who have early-stage Alzheimer’s disease.
EmblemHealth will be the first health insurer to cover Dr. Ornish’s lifestyle medicine program that enhances brain health and provides crucial support for caregivers.
Karen Ignagni, executive chair and Dr. Dan Knecht, chief medical officer of EmblemHealth, recently discussed the launch of the program in an episode of the Becker’s Payer Issues Podcast. Listen as they explore how evidence-based interventions, community support, and integrated care are reshaping brain health and advancing equity in underserved populations.
Enrollees can also receive helpful resources from EmblemHealth Neighborhood Care.
Eligibility criteria for this program include ages 45 to 90 years, current diagnosis of mild cognitive impairment or early dementia, and a Montreal Cognitive Assessment (MoCA) score of 18 to 26. If you have an EmblemHealth member who you think may qualify, please email lifestylemedicine@emblemhealth.com or call 646-447-2055 from 9 a.m. to 5 p.m., Monday through Friday.
JP 70102